Inhibitory Role of the Endothelium in the Response of Isolated Coronary Arteries to Platelets
- 15 July 1983
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 221 (4607) , 273-274
- https://doi.org/10.1126/science.6574604
Abstract
Aggregating autologous platelets caused contraction of isolated rings of canine left circumflex arteries. The contractions were augmented after removal of the endothelium and were attenuated by serotonergic antagonists. During contraction caused by prostaglandin F2 alpha, aggregating platelets caused a transient increase in tension followed by a profound relaxation of arteries with endothelium, but caused only further contraction of arteries without endothelium. These observations demonstrate the importance of the vascular endothelium in opposing the constriction of coronary vessels caused by 5-hydroxytryptamine and other substances released from aggregating platelets.This publication has 9 references indexed in Scilit:
- Prejunctional and postjunctional actions of endogenous norepinephrine at the sympathetic neuroeffector junction in canine coronary arteries.Circulation Research, 1983
- Actions of serotonin antagonists on dog coronary arteryEuropean Journal of Pharmacology, 1982
- Role of the intima in cholinergic and purinergic relaxation of isolated canine femoral arteries.The Journal of Physiology, 1981
- ERGOMETRINE CONTRACTS ISOLATED CANINE CORONARY-ARTERIES BY A SEROTONERGIC MECHANISM - NO ROLE FOR ALPHA-ADRENOCEPTORS1981
- IN-111 TROPOLONE, A NEW HIGH-AFFINITY PLATELET LABEL - PREPARATION AND EVALUATION OF LABELING PARAMETERS1981
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Coronary Artery SpasmAnnals of Internal Medicine, 1979
- Coronary Arterial Smooth Muscle Contraction by a Substance Released from Platelets: Evidence That It Is Thromboxane A 2Science, 1976
- Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N[2(ochlorophenoxy)-ethyl]-cyclopropylamineBiochemical Pharmacology, 1968